Funding @ 2018-12-03 05:50:52 UTC 3fc632bcf0a4ef6f15e6abed493d1f27aab7c4f92478e9ceaabef02c66b5397d:0
Spending @ 2018-12-05 08:35:53 UTC 5ddba5d7d9c362c5a647de3a8ced56c75f241d8cd0c437456f8adf4baa47af4c:2
|
Funding @ 2018-11-30 06:15:59 UTC 708fac08a7d2bd637009f03533bd9df5424bf0a21b98df4b2039a41468d3c440:19
Spending @ 2018-12-03 02:09:52 UTC f20e25bad51f1511e4023b72b3fc263ceeed7dcbc994fe0a36ce433c64ded3ca:0
|
Funding @ 2018-11-28 03:42:51 UTC d963962d4f9cb6a193953d16fad03f9e676e6359fde858461b37a92da0f1e637:17
Spending @ 2018-11-29 11:00:02 UTC ec19f406bf0a40ea26b1603bae1349814efa0b3dfd03044e9e4b0906d4f6e154:0
|
Funding @ 2018-11-26 06:36:56 UTC 12f89c0593fc65875224312762fc16996d3e46cce4ea25ae5653fa4aa5f2ac59:14
Spending @ 2018-11-27 04:16:10 UTC 87aead922cc825faaeb59a005ccd2d262b6d29506a92d7842ee332feef3d3275:0
|
Funding @ 2018-11-22 05:20:39 UTC e4a74a7fc95bc8981988031fb1e591a547cb0858981af2a5ad6985f83c5d77fb:1
Spending @ 2018-11-23 11:58:58 UTC ee9d2d80d6d29501136a913244e515b49954307855aba3f9d9068a1b68d33a8f:0
|
Funding @ 2018-11-19 02:55:05 UTC 6712eb5bbc0710621d104645c92a57f2c8cc48d12e64d3e0b5bb48bb1627c250:1
Spending @ 2018-11-19 20:18:34 UTC 1b7caef9c8279cf102595b8fdc4ba00b4c79a6111476002491db6babfdefb8d0:4
|
Funding @ 2018-11-14 07:27:04 UTC 5e3bcdbe2757bdf8b4cc539d17e674614a2ca4c6d85c2c6e75d929f05535ac9c:11
Spending @ 2018-11-19 06:06:11 UTC e65868a688c3f3e15c32acbb352725981e4b5cb7e6cca755dfc652fa6eb943f3:1
|
Funding @ 2018-11-04 03:04:26 UTC 4e4d248652dd61638e0e0d253fa386b0d950a5abb14985c2878fa393569f96bd:17
Spending @ 2018-11-07 04:28:42 UTC 7a714a8b00c835c6d0715df61891153ae21f5bd0e09e935a9e51ea10793a66d9:2
|
Funding @ 2018-11-01 02:20:20 UTC d77dc92ccfff0ed4fc23708009b620f58cb1ef8716ec4994ae4815b679b456c8:19
Spending @ 2018-11-05 07:42:10 UTC 05e35307c5bd21ad89fbf87af44d33df28cc2406a21aef34d997e963b081be9c:3
|
Funding @ 2018-10-29 02:14:46 UTC 3fd8a20deeb3e238e15b91971b4befd6a40fd0083894e90fcbb2115498aaeb56:15
Spending @ 2018-10-31 08:54:35 UTC ac253dafd0445110c35a40f8024d0b88b2e75394f67b957e917c815f25adfda2:5
|